FDA.reportPublic FDA data

ensifentrine 3 MG per 2.5 ML Inhalation Suspension

RxCUI
2687221
RxNorm name
ensifentrine 3 MG per 2.5 ML Inhalation Suspension
Display name
ensifentrine 3 MG per 2.5 ML Inhalation Suspension
Full name
ensifentrine 3 MG per 2.5 ML Inhalation Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e6433c98-41a0-4f99-8f7f-d0e9db6e3f40ensifentrine 3 MG in 2.5 ML Inhalation Suspension [PSN] · ensifentrine 1.2 MG/ML Inhalation Suspension [SCD] · ensifentrine 3 MG per 2.5 ML Inhalation Suspension [SY]36These highlights do not include all the information needed to use OHTUVAYRE™ safely and effectively. See full prescribing information for OHTUVAYRE. OHTUVAYRE (ensifentrine) inhalation suspension, for oral inhalation use Initial U.S. Approval: 202420260423